660 related articles for article (PubMed ID: 19224585)
41. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
43. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
[TBL] [Abstract][Full Text] [Related]
44. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
[TBL] [Abstract][Full Text] [Related]
45. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk.
Park K; Woo M; Nam J; Kim JC
Cancer Lett; 2006 Jun; 237(2):199-206. PubMed ID: 16019132
[TBL] [Abstract][Full Text] [Related]
46. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
[TBL] [Abstract][Full Text] [Related]
48. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
[TBL] [Abstract][Full Text] [Related]
49. Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.
Landi D; Gemignani F; Pardini B; Naccarati A; Garritano S; Vodicka P; Vodickova L; Canzian F; Novotny J; Barale R; Landi S
Cancer; 2012 Oct; 118(19):4670-80. PubMed ID: 22282400
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
51. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
54. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.
Tan W; Wu J; Zhang X; Guo Y; Liu J; Sun T; Zhang B; Zhao D; Yang M; Yu D; Lin D
Carcinogenesis; 2007 Jun; 28(6):1197-201. PubMed ID: 17151091
[TBL] [Abstract][Full Text] [Related]
55. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
57. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
58. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer.
Jung CY; Choi JE; Park JM; Chae MH; Kang HG; Kim KM; Lee SJ; Lee WK; Kam S; Cha SI; Kim CH; Han SB; Jung TH; Jeon SH; Park JY
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):762-8. PubMed ID: 16614121
[TBL] [Abstract][Full Text] [Related]
60. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
